Adenovirus expressing immune cell stimulatory receptor agonist(s)

University of Texas System

Abstract

Certain embodiments include the enhancement of effectiveness for an adenoviral cancer therapy.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Frank Tufaro
Priority date: November 22, 2013
Filing date: June 11, 2021
Publication date: September 30, 2021
Language: en
PDF source: https://patentimages.storage.googleapis.com/21/f4/20/38f8fcefa58182/US20210301264A1.pdf
Metadata fetched: August 29, 2026 00:27